Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Cancer gene therapy using mesenchymal stem cells.

Uchibori R, Tsukahara T, Ohmine K, Ozawa K.

Int J Hematol. 2014 Apr;99(4):377-82. doi: 10.1007/s12185-014-1537-7. Epub 2014 Mar 1. Review.

PMID:
24578184
2.

Cell and gene therapy using mesenchymal stem cells (MSCs).

Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, Mizukami H, Kume A.

J Autoimmun. 2008 May;30(3):121-7. doi: 10.1016/j.jaut.2007.12.008. Epub 2008 Jan 31. Review.

PMID:
18249090
3.

Mesenchymal stem cells: an emerging tool for cancer targeting and therapy.

Fritz V, Jorgensen C.

Curr Stem Cell Res Ther. 2008 Jan;3(1):32-42. Review.

PMID:
18220921
4.

Mesenchymal stem cells for anti-cancer drug delivery.

Gjorgieva D, Zaidman N, Bosnakovski D.

Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):310-8. Review.

PMID:
23688246
5.

Mesenchymal stem cells at the intersection of cell and gene therapy.

Myers TJ, Granero-Molto F, Longobardi L, Li T, Yan Y, Spagnoli A.

Expert Opin Biol Ther. 2010 Dec;10(12):1663-79. doi: 10.1517/14712598.2010.531257. Review.

6.

Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth.

Belmar-Lopez C, Mendoza G, Oberg D, Burnet J, Simon C, Cervello I, Iglesias M, Ramirez JC, Lopez-Larrubia P, Quintanilla M, Martin-Duque P.

BMC Med. 2013 May 28;11:139. doi: 10.1186/1741-7015-11-139.

7.

To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells.

Droujinine IA, Eckert MA, Zhao W.

Oncotarget. 2013 May;4(5):651-64. Review.

8.

Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?

Miura Y, Yoshioka S, Yao H, Takaori-Kondo A, Maekawa T, Ichinohe T.

Chimerism. 2013 Jul-Sep;4(3):78-83. doi: 10.4161/chim.25609. Epub 2013 Jul 11. Review.

9.

Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy.

Ďuriniková E, Kučerová L, Matúšková M.

Acta Virol. 2014;58(1):1-13. Review.

PMID:
24717023
10.

Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.

Zielske SP, Livant DL, Lawrence TS.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):843-53. doi: 10.1016/j.ijrobp.2008.06.1953. Epub 2008 Oct 11.

11.

Concise review: mesenchymal stem cells and translational medicine: emerging issues.

Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y, Shi Y.

Stem Cells Transl Med. 2012 Jan;1(1):51-8. doi: 10.5966/sctm.2011-0019. Epub 2011 Dec 7. Review.

12.

[Research progress of gene recombinant mesenchymal stem cells as tumor targeting delivery vehicles].

Zhang TY, Hu YL, Liang WQ, Gao JQ.

Yao Xue Xue Bao. 2013 Aug;48(8):1209-20. Review. Chinese.

PMID:
24187826
13.

Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.

Amara I, Touati W, Beaune P, de Waziers I.

Biochimie. 2014 Oct;105:4-11. doi: 10.1016/j.biochi.2014.06.016. Epub 2014 Jun 27. Review.

PMID:
24977933
14.

Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.

Payne NL, Dantanarayana A, Sun G, Moussa L, Caine S, McDonald C, Herszfeld D, Bernard CC, Siatskas C.

Cell Adh Migr. 2012 May-Jun;6(3):179-89. doi: 10.4161/cam.20341. Epub 2012 May 1.

15.

Stem cells as vectors for antitumour therapy.

Loebinger MR, Janes SM.

Thorax. 2010 Apr;65(4):362-9. doi: 10.1136/thx.2009.128025. Review.

16.

Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Porada CD, Almeida-Porada G.

Adv Drug Deliv Rev. 2010 Sep 30;62(12):1156-66. doi: 10.1016/j.addr.2010.08.010. Epub 2010 Sep 7. Review.

17.

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ.

Circ Res. 2010 Jun 11;106(11):1753-62. doi: 10.1161/CIRCRESAHA.109.196030. Epub 2010 Apr 8.

18.

Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.

Zhang X, Zhang L, Xu W, Qian H, Ye S, Zhu W, Cao H, Yan Y, Li W, Wang M, Wang W, Zhang R.

Curr Cancer Drug Targets. 2013 Jan;13(1):92-102.

PMID:
23170786
19.

Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.

Ren C, Kumar S, Chanda D, Kallman L, Chen J, Mountz JD, Ponnazhagan S.

Gene Ther. 2008 Nov;15(21):1446-53. doi: 10.1038/gt.2008.101. Epub 2008 Jul 3.

20.

Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?

Dwyer RM, Kerin MJ.

Hum Gene Ther. 2010 Nov;21(11):1506-12. doi: 10.1089/hum.2010.135. Epub 2010 Oct 6. Review.

PMID:
20649487
Items per page

Supplemental Content

Write to the Help Desk